Clinical TrialsSearch results
Number of results: 527
Recruiting
- Comparison of immune-related hepatitis and sclerosing choalngitis
- patients with immunotherapy
- Takinami Masaki
- 2021-11-02
Recruiting
- Comparison of therapeutic effects of denosumab and romosozumab using Propensity Score Matching in postmenopausal osteoporosis patients
- Primary osteoprosis
- Kobayakawa Tomonori
- 2021-01-06
Other
- Compliance study Medication Event Monitoring System-Utilizing Survey on Bisphosphonate Compliance in Osteoporotic Patients in Japan
- Osteoporotic
- JOCC [Japan Osteoporosis Central-committee for Compliance study]
- 2007-06-30
Not yet recruiting
- Computational modelig of social motivation
- Healthy adult
- Sumiya Motofumi
- 2023-07-01
Other
- Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).
- End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)
- Nagoya University
- 2006-10-01
Recruiting
- Continuous glucose monitoring for pancreatic cancer patients
- Cases scheduled for pancreatoduodenectomy for resectable pancreatic cancer.
- Sugiura Teiichi
- 2024-03-18
No Longer Recruiting
- Crutches Walking independence factor
- Fracture of lower limb,Meniscus tear,Knee ligament injury,Achilles tendon rupture
- Yamashita Teruaki
- 2022-06-11
Other
- Cyclosporine C0 monitoring for frequently relapsing nephrotic syndrome in children
- Frequently relapsing nephrotic syndrome in children
- Japanese Study Group of Renal Disease in Children
- 2005-08-01
Other
- Cyclosporine C2 monitaring for frequently relapsing nephrotic syndrome in children: A randomized controlled trial
- Frequently relapsing nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2005-08-01
Completed
- Deep brain stimulation for intractable obsessive-compulsive disorders.
- Intractable obsessive-compulsive disorders
- Nozaki Takao
- 2019-02-06